| 000 | 01746 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515063958.0 | ||
| 264 | 0 | _c20070622 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0300-483X | ||
| 024 | 7 |
_a10.1016/j.tox.2007.03.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAppiah-Opong, Regina | |
| 245 | 0 | 0 |
_aInhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. _h[electronic resource] |
| 260 |
_bToxicology _cJun 2007 |
||
| 300 |
_a83-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBenzaldehydes _xpharmacology |
| 650 | 0 | 4 |
_aCoumaric Acids _xpharmacology |
| 650 | 0 | 4 |
_aCurcumin _xchemistry |
| 650 | 0 | 4 | _aCytochrome P-450 CYP1A2 |
| 650 | 0 | 4 | _aCytochrome P-450 CYP1A2 Inhibitors |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2B6 |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2C9 |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2D6 Inhibitors |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aOxidoreductases, N-Demethylating _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVanillic Acid _xpharmacology |
| 700 | 1 | _aCommandeur, Jan N M | |
| 700 | 1 | _avan Vugt-Lussenburg, Barbara | |
| 700 | 1 | _aVermeulen, Nico P E | |
| 773 | 0 |
_tToxicology _gvol. 235 _gno. 1-2 _gp. 83-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tox.2007.03.007 _zAvailable from publisher's website |
| 999 |
_c16984134 _d16984134 |
||